Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signalling pathways for advanced HCC treatment .The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Clinical Analysis of Cells
  • AFP Blood Testing
  • Partial Hepatectomy
  • Intra - arterial Chemotherapy

Related Conference of Clinical Hepatocellular Carcinoma

September 21-22, 2018

6th International Conference on Hepatology

Osaka, Japan
October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
November 07-08, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
Feb 21-22, 2019

7th World Congress on Hepatitis & Liver Diseases

Manila, Philippines
March 04-06, 2019

20th World Congress on Gastroenterology

Berlin, Germany
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zürich, Switzerland
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Clinical Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in